Back to Results
First PageMeta Content
Antidotes / Chelating agents / Iron metabolism / Anemias / Transfusion hemosiderosis / Deferiprone / Beta-thalassemia / Iron overload / Myelodysplastic syndrome / Medicine / Chemistry / Health


Open Document

File Size: 738,89 KB

Share Result on Facebook

City

Studies / /

Company

Clinical Data Management / Pearson / Apotex Inc / /

Continent

Europe / /

Country

United States / Italy / Greece / /

Event

Product Issues / FDA Phase / /

Facility

University of Pennsylvania School / Children’s Hospital of Philadelphia In / /

IndustryTerm

chemical name / cardiac magnetic resonance imaging / quantum interference device / chemical analysis / /

MedicalCondition

inherited disorder / congestive heart failure / miscellaneous chronic anemias / transfusion-related hemosiderosis / chronic transfusion therapy / βthalassemia / myelodysplastic syndrome / inherited anemia / Transfusion-Dependent Anemia / Iron Overload / dysfunction / standard chronic therapy / anemias / chronic red blood cell transfusion / cardiac disease / sickle cell disease / cardiac hemosiderosis / hypersensitivity / thalassemia / hemosiderosis / anemia / hemochromatosis / /

MedicalTreatment

chelation therapy / red blood cell transfusions / red blood cell transfusion / /

Organization

Independent Party / University of Pennsylvania School of Medicine / Children’s Hospital of Philadelphia In / Food and Drug Administration / Review Division / FDA / Oncologic Drugs Advisory Committee / European Union / Independent Committee / Advisory Committee / /

Person

Ron Keren / Children / /

Position

Associate Professor of Pediatrics and Epidemiology / Biostatistician / /

Product

Exjade / Desferal / European Union / current chelation therapy / LA36-0310 / /

Technology

magnetic resonance imaging / MRI / CMP / /

SocialTag